PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 5 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Powdered ethanolic extract of G. aspera root exhibits antimutagenic activity in the Ames assay [PMID:28074112].
G. aspera is one of six Iranian plants tested for anti-H. pylori activities against clinical isolates [PMID:15068416].
Evidence summary
PubMed sources
- 1.PMID: 28074112 (2017) — Isolation and characterization of antimutagenic components of Glycyrrhiza aspera against N-methyl-N-nitrosourea. · Genes and environment : the official journal of the Japanese Environmental Mutagen Society
- 2.PMID: 27466044 (2017) — Antimutagenic components in Glycyrrhiza against N-methyl-N-nitrosourea in the Ames assay. · Natural product research
- 3.PMID: 36897456 (2023) — Geographic distribution and impacts of climate change on the suitable habitats of Glycyrrhiza species in China. · Environmental science and pollution research international
- 4.PMID: 33366329 (2019) — The complete chloroplast genomes of rare medical herb Glycyrrhiza inflata and its relative G. aspera (Fabaceae). · Mitochondrial DNA. Part B, Resources
- 5.PMID: 15068416